Crux Pharmaceuticals was established in 2007. Crux Pharmaceuticals provides an end-to-end solution from a business plan to a fully established company.
We have managed an oncology portfolio which was represented in the State Tender and marketed in the private sector. Some of these oncology products were first-to-market.
Crux Pharmaceuticals was also responsible for initiating the registration of the largest generic Vaccines portfolio with the South African Health Products Regulatory Authority.
We have local and International clients who are market leaders in their countries, for whom we are managing or have managed the registration process.
The Crux team consists of experienced professionals with deep knowledge of the pharmaceutical industry in South Africa and are driven to excel.
Lately,we have developed the know how to register Distributors / Wholesalers and register Medical Device companies with the Regulatory Authority.
Ajit Mangalmurti CEO
Ajit Mangalmurti has a MSc. (Pharmaceutical Affairs) degree from the University of Witwatersrand and a BCom. degree.
He has worked in various executive and senior positions in the pharmaceutical industry in several companies.